New England Journal of Medicine Publishes COVID-19 Treatment Trial Results
January 15, 2021
January 15, 2021
SAN ANTONIO, Texas, Jan. 15 (TNSJou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine. Six researchers from UT Health San Antoni . . .
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine. Six researchers from UT Health San Antoni . . .